Regulatory Filings • Dec 16, 2011
Regulatory Filings
Open in ViewerOpens in native device viewer
News Details
Corporate | 16 December 2011 10:27
STRATEC to present at two upcoming Capital Market Conferences
STRATEC Biomedical AG / Key word(s): Miscellaneous
16.12.2011 / 10:27
STRATEC to present at two upcoming Capital Market Conferences
Birkenfeld, December 16, 2011
STRATEC Biomedical AG (Frankfurt: SBS; Prime Standard, TecDAX) today announced that the company will present at two international Capital Market Conferences in January 2012:
30 th Annual J.P. Morgan Healthcare Conference
Date: January 9, 2012
Venue: San Francisco, CA, USA
CA Cheuvreux – 11 th German Corporate Conference
Date: January 17, 2012
Venue: Frankfurt/Main, Germany
Copies of the company presentation and links to the webcast, if available, will be provided at www.stratec.com > Investor Relations > Financial Calendar.
About STRATEC
STRATEC Biomedical Systems AG (www.stratec.com) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. These partners market such systems, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world.
The company develops its products on the basis of its own patented technologies. Shares in the company (ISIN: DE0007289001) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and are listed in the TecDAX select index of the German Stock Exchange.
The STRATEC Group consists of the publicly listed parent company STRATEC Systems AG and of subsidiaries and second-tier subsidiaries in Germany, the USA, the UK, Switzerland and Romania.
Further information can be obtained from:
STRATEC Biomedical AG
André Loy, Investor Relations
Gewerbestr. 37, 75217 Birkenfeld
Germany
Tel: +49 7082 7916-190
Fax: +49 7082 7916-999
www.stratec.com
End of Corporate News
16.12.2011 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
| Language: | English |
| Company: | STRATEC Biomedical AG |
| Gewerbestr. 37 | |
| 75217 Birkenfeld | |
| Germany | |
| Phone: | +49 (0)7082 7916 0 |
| Fax: | +49 (0)7082 7916 999 |
| E-mail: | [email protected] |
| Internet: | www.stratec.com |
| ISIN: | DE0007289001 |
| WKN: | 728900 |
| Listed: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart |
| End of News | DGAP News-Service |
| - - - |
| 150058 16.12.2011 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.